In the first quarter of 2023, five Biologics companies received five FDA inspections in Nevada, according to the U.S. Food and Drug Administration (FDA).
This was the highest number of inspections per type of company made by the FDA in Nevada, equalling 45.5% of all inspections in the first quarter of 2023.
Of all the Nevada companies involved in the Biologics sector, Origin Biologics, LLC received the most citations from the FDA in the first quarter of 2023.
The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.
The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 1 | 1 | — |
| Blood and Blood Products | 5 | — | — |
| Compliance: Devices | 1 | — | — |
| Foodborne Biological Hazards | 3 | — | — |
| Human Cellular, Tissue, and Gene Therapies | — | 1 | — |
| Technical Assistance: Food and Cosmetics | 3 | — | — |
| Vaccines and Allergenic Products | 5 | — | — |
